US4816570A
(en)
|
1982-11-30 |
1989-03-28 |
The Board Of Regents Of The University Of Texas System |
Biologically reversible phosphate and phosphonate protective groups
|
US4649041A
(en)
|
1983-07-20 |
1987-03-10 |
Warner-Lambert Company |
Magnesium trisilicate suitable for preparation of medicament adsorbates of antinauseants
|
DK159431C
(da)
|
1984-05-10 |
1991-03-18 |
Byk Gulden Lomberg Chem Fab |
6-phenyl-3(2h)-pyridazinoner, fremgangsmaade til fremstilling deraf, laegemidler indeholdende disse samt anvendelse af forbindelserne til fremstilling af laegemidler
|
US4968788A
(en)
|
1986-04-04 |
1990-11-06 |
Board Of Regents, The University Of Texas System |
Biologically reversible phosphate and phosphonate protective gruops
|
US5455339A
(en)
|
1986-05-01 |
1995-10-03 |
University Of Georgia Research Foundation, Inc. |
Method for the preparation of 2',3'-dideoxy and 2',3'-dideoxydide-hydro nucleosides
|
IE63869B1
(en)
|
1986-11-06 |
1995-06-14 |
Res Dev Foundation |
Aerosols containing liposomes and method for their preparation
|
FR2611203B1
(fr)
|
1987-02-20 |
1989-06-09 |
Sturtz Georges |
Analogues gem-diphosphoniques d'amethopterine (methotrexate) et de derives deaza-n-10 amethopterine. leur preparation et les compositions pharmaceutiques qui les contiennent
|
JP2737191B2
(ja)
*
|
1987-12-28 |
1998-04-08 |
東ソー株式会社 |
均質な石英ガラス塊の製造方法
|
US5631370A
(en)
|
1988-01-20 |
1997-05-20 |
Regents Of The University Of Minnesota |
Optically-active isomers of dideoxycarbocyclic nucleosides
|
US5466793A
(en)
|
1988-03-01 |
1995-11-14 |
Ajinomoto Co., Inc. |
Process for preparing 2', 3'- dideoxyinosine
|
ZA894534B
(en)
|
1988-06-20 |
1990-03-28 |
Merrell Dow Pharma |
Novel neplanocin derivatives
|
CA2001715C
(en)
|
1988-11-14 |
1999-12-28 |
Muzammil M. Mansuri |
Carbocyclic nucleosides and nucleotides
|
US5744600A
(en)
|
1988-11-14 |
1998-04-28 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Phosphonomethoxy carbocyclic nucleosides and nucleotides
|
US5202128A
(en)
|
1989-01-06 |
1993-04-13 |
F. H. Faulding & Co. Limited |
Sustained release pharmaceutical composition
|
JP2722673B2
(ja)
|
1989-05-31 |
1998-03-04 |
住友化学工業株式会社 |
光学活性なアシルビフェニル誘導体の製造法
|
DE4003574A1
(de)
|
1990-02-07 |
1991-08-08 |
Bayer Ag |
Neue dipeptide, verfahren zu ihrer herstellung und ihre verwendung als renininhibitoren in arzneimitteln
|
DK0533833T3
(da)
|
1990-06-13 |
1996-04-22 |
Arnold Glazier |
Phosphorprolægemidler
|
ATE133678T1
(de)
|
1990-07-04 |
1996-02-15 |
Merrell Dow Pharma |
9-purinyl-phosphonsäurederivate
|
US5177064A
(en)
|
1990-07-13 |
1993-01-05 |
University Of Florida |
Targeted drug delivery via phosphonate derivatives
|
EP0468119A1
(en)
|
1990-07-24 |
1992-01-29 |
Merrell Dow Pharmaceuticals Inc. |
Novel carbocyclic analogs of certain nucleosides
|
US5223618A
(en)
|
1990-08-13 |
1993-06-29 |
Isis Pharmaceuticals, Inc. |
4'-desmethyl nucleoside analog compounds
|
ES2118069T3
(es)
|
1990-09-14 |
1998-09-16 |
Acad Of Science Czech Republic |
Profarmacos de fosfonatos.
|
US5672697A
(en)
|
1991-02-08 |
1997-09-30 |
Gilead Sciences, Inc. |
Nucleoside 5'-methylene phosphonates
|
DE4111730A1
(de)
|
1991-04-10 |
1992-10-15 |
Knoll Ag |
Neue cytarabin-derivate, ihre herstellung und verwendung
|
JP2648897B2
(ja)
|
1991-07-01 |
1997-09-03 |
塩野義製薬株式会社 |
ピリミジン誘導体
|
EP0531597A1
(en)
|
1991-09-12 |
1993-03-17 |
Merrell Dow Pharmaceuticals Inc. |
Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
|
US5610294A
(en)
|
1991-10-11 |
1997-03-11 |
The Du Pont Merck Pharmaceutical Company |
Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
|
DE4138584A1
(de)
|
1991-11-23 |
1993-05-27 |
Hoechst Ag |
Carbocyclische phosphonat-nucleotidanaloge, deren herstellung und verwendung
|
GB9126144D0
(en)
|
1991-12-10 |
1992-02-12 |
British Bio Technology |
Compounds
|
FR2692265B1
(fr)
|
1992-05-25 |
1996-11-08 |
Centre Nat Rech Scient |
Composes biologiquement actifs de type phosphotriesters.
|
IS2334B
(is)
|
1992-09-08 |
2008-02-15 |
Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) |
Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
|
DE4308096A1
(de)
|
1993-03-13 |
1994-09-15 |
Hoechst Ag |
Prodrug-Derivate von Enzyminhibitoren mit Hydroxylgruppen, Verfahren zu deren Herstellung und ihre Verwendung
|
US5654286A
(en)
|
1993-05-12 |
1997-08-05 |
Hostetler; Karl Y. |
Nucleotides for topical treatment of psoriasis, and methods for using same
|
CA2126601A1
(en)
|
1993-06-29 |
1994-12-30 |
Mitsubishi Chemical Corporation |
Phosphonate-nucleotide ester derivatives
|
EP0708760A1
(en)
|
1993-07-14 |
1996-05-01 |
Novartis AG |
Cyclic hydrazine compounds
|
US5656745A
(en)
|
1993-09-17 |
1997-08-12 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
CA2171743C
(en)
|
1993-09-17 |
2007-11-20 |
Norbert W. Bischofberger |
Nucleotide analogs
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
US5493030A
(en)
|
1994-02-18 |
1996-02-20 |
Syntex (U.S.A.) Inc. |
5-substituted derivatives of mycophenolic acid
|
US5854227A
(en)
|
1994-03-04 |
1998-12-29 |
Hartmann; John F. |
Therapeutic derivatives of diphosphonates
|
WO1997011092A1
(fr)
|
1994-04-07 |
1997-03-27 |
Nippon Shinyaku Co., Ltd. |
Derives de phosphates de cyclosporine et composition medicinale
|
JP3155009B2
(ja)
|
1994-09-26 |
2001-04-09 |
塩野義製薬株式会社 |
イミダゾール誘導体
|
EP0789695A2
(en)
|
1994-11-04 |
1997-08-20 |
Gilead Sciences, Inc. |
Thiepane compounds inhibiting and detecting hiv protease
|
US5543523A
(en)
|
1994-11-15 |
1996-08-06 |
Regents Of The University Of Minnesota |
Method and intermediates for the synthesis of korupensamines
|
ES2097703B1
(es)
*
|
1995-04-12 |
1997-12-01 |
Decox S L |
Una nueva composicion estimulante de la actividad cerebral basada en alcaloides de nucleo de eburnamenina, y sus metodos de preparacion.
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
AU6299496A
(en)
|
1995-06-29 |
1997-01-30 |
Novo Nordisk A/S |
Novel substituted azabicyclic compounds
|
US5750493A
(en)
|
1995-08-30 |
1998-05-12 |
Raymond F. Schinazi |
Method to improve the biological and antiviral activity of protease inhibitors
|
US5914332A
(en)
|
1995-12-13 |
1999-06-22 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
RU2106353C1
(ru)
|
1996-03-19 |
1998-03-10 |
Корпорация "С энд Ти Сайенс энд Текнолоджи Инк." |
Соли 5'-н-фосфоната 3'- азидо-3'-дезокситимидина, являющиеся специфическими ингибиторами продукции вируса иммунодефицита человека вич-1 и вич-2
|
US5656746A
(en)
*
|
1996-03-28 |
1997-08-12 |
The Proctor & Gamble Company |
Temporary wet strength polymers from oxidized reaction product of polyhydroxy polymer and 1,2-disubstituted carboxylic alkene
|
US5874577A
(en)
|
1996-04-03 |
1999-02-23 |
Medichem Research, Inc. |
Method for the preparing 9-12-(Diethoxyphosphonomethoxy)ethyl!adenine and analogues thereof
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
JP4033494B2
(ja)
|
1996-07-26 |
2008-01-16 |
ギリヤド サイエンシーズ, インコーポレイテッド |
ヌクレオチドアナログ
|
KR20000029952A
(ko)
|
1996-08-13 |
2000-05-25 |
미우라 아끼라 |
포스포네이트뉴클레오티드화합물
|
AU4892897A
(en)
|
1996-09-17 |
1998-04-14 |
Amur Pharmaceuticals, Inc. |
Phospholipid drug derivatives
|
DE69729877T2
(de)
|
1996-10-09 |
2005-07-14 |
Pharmasset, Ltd. |
Mycophenol bisphosponatverbindungen
|
ATE261944T1
(de)
|
1996-12-26 |
2004-04-15 |
Shionogi & Co |
Verfahren zur herstellung von carbamoylsubstituierten imidazolderivaten
|
AU1810399A
(en)
|
1997-12-10 |
1999-06-28 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Method for synthesizing
|
US6436989B1
(en)
|
1997-12-24 |
2002-08-20 |
Vertex Pharmaceuticals, Incorporated |
Prodrugs of aspartyl protease inhibitors
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
US6174888B1
(en)
|
1998-05-28 |
2001-01-16 |
Novartis Ag |
2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones
|
AU4125099A
(en)
|
1998-06-01 |
1999-12-20 |
S & T Science And Technology Inc. |
Antiviral phosphorus derivatives of 4'-thio-5-ethyl-2'-deoxyuridine
|
GB9815567D0
(en)
|
1998-07-18 |
1998-09-16 |
Glaxo Group Ltd |
Antiviral compound
|
TWI260322B
(en)
|
1999-02-12 |
2006-08-21 |
Vertex Pharma |
Inhibitors of aspartyl protease
|
US6761903B2
(en)
*
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
JP5063837B2
(ja)
|
1999-03-05 |
2012-10-31 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
新規リン含有プロドラッグ
|
DE19912636A1
(de)
|
1999-03-20 |
2000-09-21 |
Aventis Cropscience Gmbh |
Bicyclische Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und pharmazeutische Mittel
|
US6258831B1
(en)
|
1999-03-31 |
2001-07-10 |
The Procter & Gamble Company |
Viral treatment
|
US6608027B1
(en)
|
1999-04-06 |
2003-08-19 |
Boehringer Ingelheim (Canada) Ltd |
Macrocyclic peptides active against the hepatitis C virus
|
DE19927689A1
(de)
*
|
1999-06-17 |
2000-12-21 |
Gruenenthal Gmbh |
Orale Darreichungsformen zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
|
WO2001000622A1
(en)
|
1999-06-25 |
2001-01-04 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of carbamate inhibitors of impdh
|
US6581606B2
(en)
|
1999-07-06 |
2003-06-24 |
The Rx Files Corporation |
Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
|
US6593292B1
(en)
|
1999-08-24 |
2003-07-15 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
GB9920872D0
(en)
|
1999-09-04 |
1999-11-10 |
Glaxo Group Ltd |
Benzophenones as inhibitors of reverse transcriptase
|
IL131887A0
(en)
|
1999-09-14 |
2001-03-19 |
Dpharm Ltd |
Phospholipid prodrugs of anti-proliferative drugs
|
CA2393410C
(en)
|
1999-12-03 |
2011-10-11 |
Karl Y. Hostetler |
Phosphonate compounds
|
AU2335801A
(en)
|
1999-12-22 |
2001-07-03 |
Merck Frosst Canada & Co. |
Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors
|
CN1426418A
(zh)
|
2000-02-29 |
2003-06-25 |
三菱制药株式会社 |
膦酸酯核苷酸化合物
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
CN1446213A
(zh)
|
2000-06-13 |
2003-10-01 |
盐野义制药株式会社 |
含丙烯酮衍生物的药用组合物
|
FR2810322B1
(fr)
|
2000-06-14 |
2006-11-10 |
Pasteur Institut |
PRODUCTION COMBINATOIRE D'ANALOGUES DE NUCLEOTIDES ET NUCLEOTIDES (XiTP)
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
US6617310B2
(en)
|
2000-07-19 |
2003-09-09 |
Bristol-Myers Squibb Pharma Company |
Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
|
NZ535408A
(en)
|
2000-07-21 |
2006-09-29 |
Gilead Sciences Inc |
Method for selecting prodrugs of phosphonate nucleotide analogues
|
US6420586B1
(en)
|
2000-08-15 |
2002-07-16 |
University Of Kansas |
Amino acid-derived cyclic phosphonamides and methods of synthesizing the same
|
DE60124117T8
(de)
|
2000-09-08 |
2007-05-31 |
Zeria Pharmaceutical Co., Ltd. |
Aminothiazol-derivate enthaltende pharmazeutische zusammensetzungen zur behandlung von motorischen störungen des kolons
|
RU2188203C2
(ru)
|
2000-10-05 |
2002-08-27 |
Государственный научный центр вирусологии и биотехнологии "Вектор" |
2',3'-дидегидро-2',3'-дидезокситимидин-5'[(этоксикарбонил)(этил)фосфонат]- ингибитор репродукции вируса иммунодефицита человека
|
GB0028429D0
(en)
|
2000-11-22 |
2001-01-10 |
Astrazeneca Ab |
Therapy
|
JP2005502580A
(ja)
|
2000-12-15 |
2005-01-27 |
フアーマセツト・リミテツド |
フラビウィルス感染治療用抗ウィルス薬
|
CN1238363C
(zh)
|
2000-12-28 |
2006-01-25 |
橘生药品工业株式会社 |
吡喃葡糖氧基吡唑衍生物及其在药物中的应用
|
HUP0400726A3
(en)
|
2001-01-22 |
2007-05-29 |
Merck & Co Inc |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
PL363321A1
(en)
|
2001-01-31 |
2004-11-15 |
Warner-Lambert Company Llc |
Method for carbamoylating alcohols
|
EP1864967A1
(en)
|
2001-02-12 |
2007-12-12 |
Wyeth |
Method for preparing O-desmethyl-venlafaxine
|
US6962684B2
(en)
|
2001-05-31 |
2005-11-08 |
Sumitomo Chemical Company, Limited |
Activated alumina formed body and method for producing the same
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
KR20020097384A
(ko)
|
2001-06-20 |
2002-12-31 |
미쯔비시 도꾜 세이야꾸 가부시끼가이샤 |
기존의 약제에 내성변이를 가지는 바이러스에 유효한 약제
|
NZ530098A
(en)
|
2001-06-20 |
2006-02-24 |
Nuevolution As |
Templated molecules and methods for using such molecules
|
EP1408984B1
(de)
|
2001-07-20 |
2008-10-22 |
BioAgency AG |
Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen
|
ES2330089T3
(es)
|
2001-08-17 |
2009-12-04 |
Mitsui Chemicals Agro, Inc. |
Derivado de 3-fenoxi-4-piridazinol y composicion herbicida que lo contiene.
|
JP2005508924A
(ja)
|
2001-08-30 |
2005-04-07 |
三菱ウェルファーマ株式会社 |
抗ウイルス剤
|
ES2258652T3
(es)
|
2001-11-29 |
2006-09-01 |
Pfizer Products Inc. |
Sales de succinato de 5,8,14-triazatetraciclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de los mismos.
|
WO2003050129A1
(en)
|
2001-12-07 |
2003-06-19 |
Eli Lilly And Company |
Use of phosphonate nucleotide analogue for treating hepatitis b virus infections
|
RS46404A
(en)
*
|
2001-12-12 |
2006-10-27 |
Pfizer Products Inc. |
Salt forms of e-2-methoxy-n-(3-(4-(3-methyul-pyridin-3- yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide,its preparation and its use against cancer
|
HU230216B1
(hu)
|
2001-12-21 |
2015-10-28 |
Eisai Inc. |
Eljárás alkoholok és fenolok vízoldható foszfonooximetil-származékai előállítására
|
US20030198666A1
(en)
|
2002-01-07 |
2003-10-23 |
Richat Abbas |
Oral insulin therapy
|
KR101004224B1
(ko)
|
2002-02-01 |
2010-12-27 |
어리어드 파마슈티칼스, 인코포레이티드 |
인 함유 화합물 및 이의 용도
|
US7465718B2
(en)
|
2002-02-08 |
2008-12-16 |
Conforma Therapeutics Corporation |
Ansamycins having improved pharmacological and biological properties
|
US7927613B2
(en)
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
AU2003216523A1
(en)
|
2002-03-18 |
2003-10-08 |
Mitsubishi Pharma Corporation |
Treatment of pre-core hepatitis b virus mutant infections
|
WO2003087090A2
(en)
|
2002-04-10 |
2003-10-23 |
Ortho-Mcneil Pharmaceutical,Inc. |
Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
|
US20050239054A1
(en)
|
2002-04-26 |
2005-10-27 |
Arimilli Murty N |
Method and compositions for identifying anti-HIV therapeutic compounds
|
MXPA04010527A
(es)
|
2002-04-26 |
2004-12-13 |
Gilead Sciences Inc |
Acumulacion celular de analogos de fosfonato de los compuestos inhibidores de la proteasa del virus de inmunodeficiencia humana (vih).
|
US6872827B2
(en)
*
|
2002-04-26 |
2005-03-29 |
Chembridge Research Laboratories, Inc. |
Somatostatin analogue compounds
|
US6808572B2
(en)
*
|
2002-05-15 |
2004-10-26 |
Aerojet-General Corporation |
Solid propellant formulations and methods and devices employing the same for the destruction of airborne biological and/or chemical agents
|
CA2499819A1
(en)
|
2002-09-30 |
2004-04-08 |
A/S Gea Farmaceutisk Fabrik |
Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
|
US20040157793A1
(en)
|
2002-11-12 |
2004-08-12 |
Stuyver Lieven J. |
Modified nucleosides as antiviral agents
|
EP1653976A4
(en)
|
2003-02-19 |
2009-07-29 |
Univ Yale |
ANTIVIRAL NUCLEOSIDE ANALOGUES AND METHODS FOR TREATING VIRAL INFECTIONS, IN PARTICULAR HIV INFECTIONS
|
WO2004096285A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-infective phosphonate conjugates
|
US7417055B2
(en)
|
2003-04-25 |
2008-08-26 |
Gilead Sciences, Inc. |
Kinase inhibitory phosphonate analogs
|
WO2004096233A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Nucleoside phosphonate conjugates
|
WO2004096237A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
CN101410120A
(zh)
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
KR20060028632A
(ko)
|
2003-04-25 |
2006-03-30 |
길리애드 사이언시즈, 인코포레이티드 |
항염증 포스포네이트 화합물
|
MXPA05011289A
(es)
|
2003-04-25 |
2006-01-24 |
Gilead Sciences Inc |
Compuestos de fosfato que tienen actividad inmunomoduladora.
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
US7427636B2
(en)
|
2003-04-25 |
2008-09-23 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
EP1628685B1
(en)
|
2003-04-25 |
2010-12-08 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
BRPI0409680A
(pt)
|
2003-04-25 |
2006-04-18 |
Gilead Sciences Inc |
análogos de fosfonato anti-cáncer
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
WO2004096887A1
(ja)
|
2003-05-02 |
2004-11-11 |
Kaneka Corporation |
反応性珪素基含有有機重合体
|
EP1626950A4
(en)
|
2003-05-23 |
2007-05-23 |
Transform Pharmaceuticals Inc |
SERTRALINZUSAMMENSETZUNGEN
|
CA2798163A1
(en)
|
2003-06-16 |
2004-12-23 |
Ajinomoto Co., Inc. |
Inosine derivatives and production methods therefor
|
US7579332B2
(en)
|
2003-07-30 |
2009-08-25 |
Gilead Sciences, Inc. |
Nucleobase phosphonate analogs for antiviral treatment
|
EP1658276B1
(en)
*
|
2003-08-18 |
2012-10-10 |
H. Lundbeck A/S |
Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
|
CA2543144A1
(en)
|
2003-10-24 |
2005-05-12 |
Gilead Sciences, Inc. |
Methods and compositions for identifying therapeutic compounds
|
US7432273B2
(en)
|
2003-10-24 |
2008-10-07 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
US7427624B2
(en)
|
2003-10-24 |
2008-09-23 |
Gilead Sciences, Inc. |
Purine nucleoside phosphorylase inhibitory phosphonate compounds
|
CA2548951A1
(en)
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
US20080287471A1
(en)
|
2003-12-22 |
2008-11-20 |
Maria Fardis |
4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity
|
EP1550665A1
(en)
|
2003-12-26 |
2005-07-06 |
Ajinomoto Co., Inc. |
A process for the production of purine nucleoside compounds
|
US7404949B2
(en)
|
2004-03-15 |
2008-07-29 |
Unilever Home & Personal Care Usa, Division Of Conopco, Inc. |
Methods and compositions useful to prevent in-grown hair arising from shaving
|
CA2570389A1
(en)
*
|
2004-06-17 |
2005-12-29 |
Osteologix A/S |
Treatments comprising strontium for rheumatic and arthritic diseases and pain
|
PL216369B1
(pl)
|
2004-07-27 |
2014-03-31 |
Gilead Sciences |
Pochodne fosfonianowe, kompozycje farmaceutyczne zawierające te pochodne oraz zastosowanie tych pochodnych do wytwarzania leku do hamowania wirusa HIV
|
US20060181714A1
(en)
|
2004-07-29 |
2006-08-17 |
Coherix, Inc |
Method for processing multiwavelength interferometric imaging data
|
US20060069060A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Sanjeev Redkar |
Salts of decitabine
|
US7154505B2
(en)
|
2004-11-11 |
2006-12-26 |
Stonecube Limited |
Method of and apparatus for generating a representation of an object
|
KR20060080817A
(ko)
|
2005-01-06 |
2006-07-11 |
씨제이 주식회사 |
시부트라민의 디카복실산염
|
MY148074A
(en)
*
|
2005-05-10 |
2013-02-28 |
Novartis Ag |
Pharmaceutical compositions comprising imatinib and a release retardant
|
MX2008001609A
(es)
*
|
2005-08-04 |
2008-02-19 |
Novartis Ag |
Sales de vildagliptina.
|
DE102005041860A1
(de)
*
|
2005-09-02 |
2007-03-08 |
Schering Ag |
Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen
|
CA2632540A1
(en)
*
|
2005-12-16 |
2007-07-05 |
Wyeth |
Lyophilized compositions of a triazolopyrimidine compound
|
US20060223820A1
(en)
*
|
2006-03-21 |
2006-10-05 |
Chemagis Ltd. |
Crystalline aripiprazole salts and processes for preparation and purification thereof
|
US8895531B2
(en)
|
2006-03-23 |
2014-11-25 |
Rfs Pharma Llc |
2′-fluoronucleoside phosphonates as antiviral agents
|
KR101436647B1
(ko)
*
|
2006-05-26 |
2014-09-02 |
3디 시스템즈 인코오퍼레이티드 |
3d 프린터 내에서 재료를 처리하기 위한 인쇄 헤드 및 장치 및 방법
|
DE102006036330A1
(de)
|
2006-08-03 |
2008-02-07 |
Ccs Technology Inc., Wilmington |
Vorrichtung zum Spleißen von Lichtwellenleiterabschnitten
|
LT2487166T
(lt)
|
2007-02-23 |
2016-11-10 |
Gilead Sciences, Inc. |
Terapinių agentų farmakokinetinių savybių moduliatoriai
|
US20090163449A1
(en)
|
2007-12-20 |
2009-06-25 |
Eastman Chemical Company |
Sulfo-polymer powder and sulfo-polymer powder blends with carriers and/or additives
|
PE20110219A1
(es)
|
2008-07-08 |
2011-03-31 |
Gilead Sciences Inc |
Sales del compuesto n-[(s)({[(2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofuran-2-il]oxi}metil)fenoxifosfinoil]-l-alaninato de etilo como inhibidores de vih
|
JP4330086B1
(ja)
|
2009-02-09 |
2009-09-09 |
株式会社テクネス |
非酸化物セラミックス製品の製造方法
|
EP2305680A3
(en)
|
2009-09-30 |
2011-05-18 |
Aurobindo Pharma Limited |
Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
|
US20140094609A1
(en)
|
2012-10-03 |
2014-04-03 |
Gilead Sciences, Inc. |
Process for the preparation of an hiv integrase inhibitor
|
US20140094485A1
(en)
|
2012-10-03 |
2014-04-03 |
Gilead Sciences, Inc. |
Solid state forms of hiv inhibitor
|